Style | Citing Format |
---|---|
MLA | Gorabi AM, et al.. "Epigenetic Control of Atherosclerosis Via Dna Methylation: A New Therapeutic Target?." Life Sciences, vol. 253, no. , 2020, pp. -. |
APA | Gorabi AM, Penson PE, Banach M, Motallebnezhad M, Jamialahmadi T, Sahebkar A (2020). Epigenetic Control of Atherosclerosis Via Dna Methylation: A New Therapeutic Target?. Life Sciences, 253(), -. |
Chicago | Gorabi AM, Penson PE, Banach M, Motallebnezhad M, Jamialahmadi T, Sahebkar A. "Epigenetic Control of Atherosclerosis Via Dna Methylation: A New Therapeutic Target?." Life Sciences 253, no. (2020): -. |
Harvard | Gorabi AM et al. (2020) 'Epigenetic Control of Atherosclerosis Via Dna Methylation: A New Therapeutic Target?', Life Sciences, 253(), pp. -. |
Vancouver | Gorabi AM, Penson PE, Banach M, Motallebnezhad M, Jamialahmadi T, Sahebkar A. Epigenetic Control of Atherosclerosis Via Dna Methylation: A New Therapeutic Target?. Life Sciences. 2020;253():-. |
BibTex | @article{ author = {Gorabi AM and Penson PE and Banach M and Motallebnezhad M and Jamialahmadi T and Sahebkar A}, title = {Epigenetic Control of Atherosclerosis Via Dna Methylation: A New Therapeutic Target?}, journal = {Life Sciences}, volume = {253}, number = {}, pages = {-}, year = {2020} } |
RIS | TY - JOUR AU - Gorabi AM AU - Penson PE AU - Banach M AU - Motallebnezhad M AU - Jamialahmadi T AU - Sahebkar A TI - Epigenetic Control of Atherosclerosis Via Dna Methylation: A New Therapeutic Target? JO - Life Sciences VL - 253 IS - SP - EP - PY - 2020 ER - |